Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Effects on Food Motivation
NCT02276677Phase 1Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2014
- Primary completion
- May 2015
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of oxytocin nasal spray in obesity and Overweight (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Change in functional magnetic resonance imaging activation of food motivation brain regions. Started Oct 2014; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT02276677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276677.